Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · T. Rowe Price

MassMutual Small Cap Growth Equity Fund Class R3 (MSGNX)

Ticker MSGNX · · Holdings as of Jun 30, 2026

Expense ratio
1.55%$155/yr per $10k
5-yr return
+3.6%annualized
1-yr return
+10.5%as of Dec 2025
Net assets
$736.4Mall share classes
Holdings
258

Bottom line

Is MSGNX a good fund? The bottom line

MSGNX is the Class R3 share class of MassMutual Small Cap Growth Equity Fund, an actively managed small-cap mutual fund from T. Rowe Price.

It charges 1.55% — about $155 a year on every $10,000 invested, more expensive than 87% of small-cap funds we track.

It returned +10.5% over one year, +3.6% a year over five years, +10.9% a year over ten (as of Dec 31, 2025, per its prospectus).

With $736 million in net assets and 258 holdings, its largest position is MKS Inc (2.1%) and the top 10 make up 14.1% of the portfolio.

What stands out

  • Broadly diversified (258 holdings)
  • No front-end sales load

What to watch

  • Expensive for its category (1.55%)
  • 5-year return in the bottom quarter of its category
  • 12b-1 marketing fee of 0.5% a year

Updated Nov 19, 2026

What MSGNX invests in

This Fund seeks long-term capital appreciation.

Principal Investment Strategies The Fund invests primarily in equity securities of smaller companies that the Funds subadvisers believe offer potential for long-term growth. Under normal circumstances, the Fund invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in the equity securities of companies whose market capitalizations at the time of purchase are within the market capitalization range of companies included in the Russell 2000 Index or the S&P SmallCap 600 Index (as of December 31, 2025, between $ 5.61 million and $31.15 billion ). Equity securities may include common stocks, preferred stocks, securities convertible into common or preferred stock, rights, and warrants. While most assets typically will be invested in common stocks of U.S. companies, the Fund also may invest up to 20% of its total assets in foreign securities…

From the fund's prospectus (filed Jan 30, 2026).

MSGNX performance

Average annual total returns
1 yr5 yr10 yr
MSGNX+10.5%+3.6%+10.9%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full MSGNX performance history →

What MSGNX costs

On a $10,000 investment, MSGNX's 1.55% expense ratio costs about $155 a year. The prospectus estimates $1,874 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full MSGNX fee table →

MSGNX top 10 holdings

#Holding% of fund
1MKS Inc2.07%
2Fixed Income Clearing Corp.1.89%
3State Street Global Advisors1.79%
4SiTime Corp1.46%
5Modine Manufacturing Co1.32%
6Alignment Healthcare Inc1.32%
7ESCO Technologies Inc1.12%
8BrightSpring Health Services Inc1.07%
9Sanmina Corp1.05%
10Protagonist Therapeutics Inc1.05%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 14.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to MSGNX

More funds like MSGNX →

MSGNX FAQ

What is the expense ratio of MSGNX?
MSGNX's expense ratio is 1.55%, which works out to about $155 a year for every $10,000 invested. The prospectus estimates total costs of $1,874 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MSGNX a good investment?
It depends on your goals, but the data points to: broadly diversified (258 holdings); no front-end sales load; expensive for its category (1.55%); 5-year return in the bottom quarter of its category; 12b-1 marketing fee of 0.5% a year. This is general information, not personalized advice.
What does MSGNX hold?
MSGNX's largest holdings are MKS Inc (2.1%), Fixed Income Clearing Corp. (1.9%), State Street Global Advisors (1.8%), SiTime Corp (1.5%), Modine Manufacturing Co (1.3%). It holds 258 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is MSGNX's 5-year return?
MSGNX returned +3.6% a year over the five years ending Dec 31, 2025, and +10.9% a year over ten years. Past performance does not guarantee future results.
Does MSGNX have a sales load?
No. MSGNX has no front-end sales charge.
Who manages MSGNX?
MSGNX is offered by T. Rowe Price through Massmutual Select Funds.